Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Y-Mabs Therapeutics (YMAB) has issued an announcement.
Gérard Ber, Ph.D., has announced his resignation from the Board of Directors of Y-mAbs Therapeutics, effective June 10, 2024. The departure is amicable, with no disagreements over operations, policies, or practices cited. Dr. Ber will continue to offer his expertise to the company in a consultative capacity post-resignation, and the company has expressed gratitude for his dedication and service.
Learn more about YMAB stock on TipRanks’ Stock Analysis page.